Your Premium Trade Alerts (Jun 29)

Dear Fellow Trader, I hope this trading day has been good to you! I am sending you trade ideas for tomorrow (Jun 30). So you can have enough time to take action on our trades ideas. I am giving away over $1000 worth of bonuses for the next 4 days. Absolutely FREE! Sign up today and get complete access to Stock Trade Alerts (generated verifiable 260.9% profit), Options Trade Ideas (Simple Calls and Puts Buy), advanced earnings screener (the best tool to find actionable trading ideas), and of course a lot more. GET ACCESS NOW AND CLAIM YOUR $1,000 BONUSES Options Trade Ideas (Volatility Rush Strategy) The basic option trade idea is to buy an at-the-money straddle while the options premium is cheap. In assessing this trade, you need to do your homework to ensure you are not paying too much for the straddle. As the earnings date approaches, the implied volatility (IV) should increase, making your straddle profitable. However, be aware that you should close your position before the announcement comes out in order to maximize your profit potential. That's because once earnings are released, IV will fall dramatically, which will greatly reduce your opportunity to profit on the trade. The stocks (with Weekly Options) below are announcing earnings in next few weeks. Our proprietary volatility algorithm suggests these stocks are likely to experience high volatility as earnings day approaches. Symbol Company Earning Date Predicted Volatility * CMG Chipotle Mexica.. 07/20 7% INTC Intel Corp 07/22 4% TWTR Twitter Inc 07/22 12% CLF Cleveland-Cliff.. 07/22 7% ADS Alliance Data S.. 07/22 5% AAL American Airlin.. 07/22 4% OLN OLIN Corp 07/27 4% PHM Pultegroup Inc 07/27 4% QCOM Qualcomm Inc 07/28 5% =Before Market Open =After Market Close *Predicted Volatility % based on our Proprietary Volatility Predication Model. We are expecting that stock price will likely to reach % in either direction by the end of next trading session after Earnings are released and not necessarily the closing volatility %. [Ad] Clinical trial shows promising result for patients AND investors This company Outlines Plans for Advancing Its Brain Cancer Drug Which Received Positive FDA Pre-IND Guidance Click Now to Learn More! At StockEarnings, we're really excited to help you trade more profitably. To that end, we're constantly developing new content to go alongside our platform insights, which will further our mission to help you become a better trader. To your trading success, Hiral Ghelani Founder & CEO StockEarnings,  Inc 110 Wall Street, Suite #2046, New York, NY 10005 W: 877.6.STOCKS (Mon to Sat | 9am to 5pm EST | Feel Free to Call Us) StockEarnings is a research service not owned or managed by registered brokers and therefore this site does not make any investment recommendations. The information provided from StockEarnings is not guaranteed as to the accuracy or completeness. Neither StockEarnings, its principals, or publishers, are liable for any losses or damages, monetary or otherwise, that result from the content and services of StockEarnings. Each member of StockEarnings chooses to do trades at their sole discretion and risk. StockEarnings is not responsible for gains/losses that may result in the trading of these securities. Unsubscribe